Two-year efficacy, safety, and drug survival of dupilumab for atopic dermatitis: A real-world Canadian multicenter retrospective study

被引：20
|
作者：
Georgakopoulos, Jorge R. [1 ]
Felfeli, Tina [2 ,3 ]
Drucker, Aaron M. [1 ,3 ,4 ]
Jo, Christine E. [5 ]
Piguet, Vincent [1 ,4 ]
Yeung, Jensen [1 ,6 ,7 ,8 ]
机构：
[1] Univ Toronto, Dept Med, Div Dermatol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Ophthalmol & Vis Sci, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[4] Womens Coll Hosp, Toronto, ON, Canada
[5] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[7] Prob Med Res Inc, Waterloo, ON, Canada
[8] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,Fifth Floor, Toronto, ON M5S 1B2, Canada
来源：
JAAD INTERNATIONAL | 2021年 / 4卷
关键词：
adverse event; atopic dermatitis; drug survival; dupilumab; efficacy; safety;
D O I：
10.1016/j.jdin.2021.06.001
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：67 / 69
页数：3
相关论文
共 50 条
  • [41] Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
    Beyrouti, Alexandre
    Deuze, Juliette
    Fontas, Eric
    Foureau, Aurore
    Barbarot, Sebastien
    Aubert, Helene
    Bernier, Claire
    Le Moigne, Marie
    Passeron, Thierry
    Boukari, Feriel
    Garnier, Margaux
    Jachiet, Marie
    Tetart, Florence
    Seneschal, Julien
    Toussaiant, Clementine
    Mah, Emmanuel
    Leleu, Camille
    Regnault, Marie Masson
    Pasteur, Justine
    Nosbaum, Audrey
    Badaoui, Antoine
    Fougerousse, Anne-Claire
    Pralong, Pauline
    Viguier, Manuelle
    Droitcourt, Catherine
    Abasq, Claire
    Mallet, Phanie
    Mallet, Stephaine
    Raison-Peyron, Nadia
    Staumont-Sall, Delphine
    Hubiche, Thomas
    Grp Recherche Atopique GREAT Res Grp
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (02) : 353 - 360
  • [42] Long-Term Efficacy and Safety of Dupilumab in Patients with Atopic Dermatitis: A Single-Centre Retrospective Study
    Ortoncelli, Michela
    Macagno, Nicole
    Mastorino, Luca
    Gelato, Federica
    Richiardi, Irene
    Cavaliere, Giovanni
    Quaglino, Pietro
    Ribero, Simone
    COSMETICS, 2023, 10 (06)
  • [43] Safety and effectiveness of dupilumab in the real-world treatment of atopic dermatitis in Japan: 1-year interim analysis from a post-marketing surveillance
    Saeki, Hidehisa
    Fujita, Hiroyuki
    Suzuki, Katsuhisa
    Arima, Kazuhiko
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 78 - 87
  • [44] Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry
    Kojanova, Martina
    Tanczosova, Milena
    Strosova, Daniela
    Cetkovska, Petra
    Fialova, Jorga
    Dolezal, Tomas
    Machovcova, Alena
    Gkalpakiotis, Spyridon
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2578 - 2586
  • [45] Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
    Lawrence F. Eichenfield
    April Armstrong
    Emma Guttman-Yassky
    Peter A. Lio
    Chi-Chang Chen
    Dionne M. Hines
    Catherine B. McGuiness
    Sohini Ganguli
    Dimittri Delevry
    Debra Sierka
    Usha G. Mallya
    Dermatology and Therapy, 2022, 12 : 1337 - 1350
  • [46] Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
    Faiz, Sarah
    Giovannelli, Jonathan
    Podevin, Celine
    Jachiet, Marie
    Bouaziz, Jean-David
    Reguiai, Ziad
    Nosbaum, Audrey
    Lasek, Audrey
    le Bouedec, Marie-Christine Ferrier
    Aurelie Du Thah
    Raison-Peyron, Nadia
    Tetart, Florence
    Duval-Modeste, Anne-Benedicte
    Misery, Laurent
    Aubin, Francois
    Dompmartin, Anne
    Morice, Cecile
    Droitcourt, Catherine
    Soria, Angele
    Arnault, Jean-Philippe
    Delaunay, Juliette
    Mahe, Emmanuel
    Richard, Marie-Aleth
    Schoeffler, Amelie
    Lacour, Jean-Philippe
    Begon, Edouard
    Walter-Lepage, Amelie
    Dillies, Anne-Sophie
    Rappelle-Duruy, Sandrine
    Barete, Stephane
    Bellon, Nathalia
    Beneton, Nathalie
    Valois, Aude
    Barbarot, Sebastien
    Senechal, Julien
    Staumont-Salle, Delphine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 143 - 151
  • [47] Patient-reported outcomes and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study
    Murrell, Dedee F.
    Ferrucci, Silvia M.
    Foti, Caterina
    Perez-Garcia, Bibiana
    Lapeere, Hilde
    Calzavara-Pinton, Piergiacomo
    Fougerousse, Anne-Claire
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [48] Physician-assessed effectiveness and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study
    Ferrucci, Silvia M.
    Calzavara-Pinton, Piergiacomo
    Karlova, Iva
    Lapeere, Hilde
    Holzer, Gregor
    Al-Ahmad, Mona
    Chu, Chia-Yu
    Wu, Jiangming
    Ardeleanu, Marius
    Bosman, Kwinten
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [49] Comparison of Efficacy of Baricitinib and Dupilumab in the Treatment of Chinese Moderate-To-Severe Atopic Dermatitis: A Retrospective Study
    Liu, Bo
    Song, Xiaoting
    Liao, Shuanglu
    Luan, Tingting
    Zhao, Zuotao
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (10) : 966 - 974
  • [50] A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries
    Alfalasi, Amani
    Ameen, Ahmed
    Al Lafi, Atlal
    El Gendi, Ayman
    Saad, Waqas
    Ismail, Ahmed
    Al Naeem, Ayman
    Goturu, Srikumar
    Al-Ahmed, Nasser
    Dayem, Hussein Abdel
    Nanda, Arti
    Tawdy, Amira
    Alogayell, Lulwa
    Iraqi, Mohamed
    Abdul Hay, Nasser
    El Enezi, Manar
    Walkhinde, Subash
    Kamal, Marwa
    Aldhuhoori, Muna
    Almesfer, Asem
    Abd Elwhab, Amira
    Al Hawsawi, Khalid Ali
    Barakat, Ahmad
    Chmayse, Sahar
    Hafiz, Mohammed
    Chouikrat, Zahir
    Fahmy, Monica
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
12345